We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Windtree Therapeutics Com | NASDAQ:DSCO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.50 | 0 | 01:00:00 |
T | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware
|
|
94-3171943
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
|
2600 Kelly Road, Suite 100
|
|
|
Warrington, Pennsylvania 18976-3622
|
|
|
(Address of principal executive offices)
|
|
Large accelerated filer
|
o
|
Accelerated filer
|
T
|
|
|
|
|
Non-accelerated filer
|
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
o
|
|
|
DISCOVERY LABORATORIES, INC.
|
|
|
|
(Registrant)
|
|
|
|
|
|
Date:
|
February 7, 2014
|
By:
|
/s/ John G. Cooper
|
|
|
|
John G. Cooper
|
|
|
|
President and Chief Executive Officer and Chief Financial Officer (Principal Executive and Financial Officer)
|
Exhibit No.
|
|
Description
|
|
Method of Filing
|
|
|
|
|
|
3.1
|
|
Amended and Restated Certificate of Incorporation of Discovery Laboratories, Inc. (Discovery) filed as of August 1, 2013, including amendments reflected in a Certificate of Amendment to the Restated Certificate of Incorporation of Discovery filed on December 27, 2010, and in a Certificate of Amendment to the Restated Certificate of Incorporation of Discovery filed on October 3, 2011
|
|
Incorporated by reference to Exhibit 3.1 to Discovery's Quarterly Report on Form 10-Q for the quarter ended June 30, 2013, as filed with the SEC on August 8, 2013.
|
|
|
|
|
|
3.2
|
|
Certificate of Designations, Preferences and Rights of Series A Junior Participating Cumulative Preferred Stock of Discovery, dated February 6, 2004
|
|
Incorporated by reference to Exhibit 2.2 to Discovery's Form 8-A, as filed with the SEC on February 6, 2004.
|
|
|
|
|
|
3.3
|
|
Amended and Restated By-Laws of Discovery, as amended effective September 3, 2009
|
|
Incorporated by reference to Exhibit 3.1 to Discovery's Current Report on Form 8-K, as filed with the SEC on September 4, 2009.
|
|
|
|
|
|
4.1
|
|
Shareholder Rights Agreement, dated as of February 6, 2004, by and between Discovery and Continental Stock Transfer & Trust Company
|
|
Incorporated by reference to Exhibit 10.1 to Discovery's Current Report on Form 8-K, as filed with the SEC on February 6, 2004.
|
|
|
|
|
|
4.2
|
|
Warrant Agreement dated May 22, 2008 by and between Kingsbridge Capital Limited and Discovery
|
|
Incorporated by reference to Exhibit 4.1 to Discovery's Current Report on Form 8-K as filed with the SEC on May 28, 2008.
|
|
|
|
|
|
4.3
|
|
Warrant Agreement dated December 12, 2008 by and between Kingsbridge Capital Limited and Discovery
|
|
Incorporated by reference to Exhibit 4.1 to Discovery's Current Report on Form 8-K, as filed with the SEC on December 15, 2008.
|
|
|
|
|
|
4.4
|
|
Form of Stock Purchase Warrant issued in May 2009
|
|
Incorporated by reference to Exhibit 10.3 to Discovery's Current Report on Form 8-K, as filed with the SEC on May 8, 2009.
|
|
|
|
|
|
4.5
|
|
Form of Stock Purchase Warrant issued in February 2010
|
|
Incorporated by reference to Exhibit 4.1 to Discovery's Current Report on Form 8-K, as filed with the SEC on February 18, 2010.
|
|
|
|
|
|
4.6
|
|
Warrant Agreement, dated as of April 30, 2010, by and between Discovery and PharmaBio
|
|
Incorporated by reference to Exhibit 4.1 to Discovery's Current Report on Form 8-K, as filed with the SEC on April 28, 2010.
|
|
|
|
|
|
4.7
|
|
Warrant Agreement dated June 11, 2010 by and between Kingsbridge Capital Limited and Discovery
|
|
Incorporated by reference to Exhibit 4.1 to Discovery's Current Report on Form 8-K, as filed with the SEC on June 14, 2010.
|
|
|
|
|
|
Exhibit No.
|
Description
|
Method of Filing
|
||
4.8
|
|
Form of Series I Warrant to Purchase Common Stock issued on June 22, 2010 (Five-Year Warrant)
|
|
Incorporated by reference to Exhibit 4.1 to Discovery's Current Report on Form 8-K, as filed with the SEC on June 17, 2010.
|
|
|
|
|
|
4.9
|
|
Warrant Agreement, dated as of October 12, 2010, by and between Discovery and PharmaBio
|
|
Incorporated by reference to Exhibit 4.1 to Discovery's Current Report on Form 8-K, as filed with the SEC on October 13, 2010.
|
|
|
|
|
|
4.10
|
|
Form of Series I Warrant to Purchase Common Stock issued on February 22, 2011 (Five-Year Warrant)
|
|
Incorporated by reference to Exhibit 4.1 to Discovery's Current Report on Form 8-K, as filed with the SEC on February 16, 2011.
|
|
|
|
|
|
4.11
|
|
Form of Series II Warrant to Purchase Common Stock issued on February 22, 2011
|
|
Incorporated by reference to Exhibit 4.2 to Discovery's Current Report on Form 8-K, as filed with the SEC on February 16, 2011.
|
|
|
|
|
|
4.12+
|
|
Form of Warrant issued to Deerfield Private Design Fund II, L.P., Deerfield Private Design International II, L.P., Deerfield Special Situations Fund, L.P. and Deerfield Special Situations International Master Fund, L.P. (collectively, "Deerfield") under a Facility Agreement dated as of February 13, 2013 between Discovery and Deerfield ("Deerfield Facility")
|
|
Incorporated by reference to Exhibit 4.1 to Discovery's Current Report on Form 8-K/A, as filed with the SEC on March 15, 2013.
|
|
|
|
|
|
4.13
|
|
Form of Notes issued to Deerfield evidencing loan under Deerfield Facility
|
|
Incorporated by reference to Exhibit 4.2 to Discovery's Current Report on Form 8-K/A, as filed with the SEC on March 15, 2013.
|
|
|
|
|
|
10.1
|
|
Extension, dated as of July 16, 2013, of Lease dated as of December 3, 2004, between Discovery, as successor-in-interest to Laureate Pharma, Inc. ("Tenant"), and Norwell Land Company , with respect to property at 710 Union Blvd., Totowa, NJ 07512
|
|
Incorporated by reference to Exhibit 10.1 to Discovery's Quarterly Report on Form 10-Q for the quarter ended June 30, 2013, as filed with the SEC on August 8, 2013.
|
|
|
|
|
|
10.2+
|
|
Pharmaceutical Manufacturing and Supply Agreement dated August 7, 2013 between Discovery and DSM Pharmaceuticals, Inc. ("DSM")
|
|
Incorporated by reference to Exhibit 10.2 to Discovery's Quarterly Report on Form 10-Q for the quarter ended June 30, 2013, as filed with the SEC on August 8, 2013.
|
|
|
|
|
|
|
Master Services Agreement dated October 24, 2013 between Discovery and DSM
|
|
Filed herewith.
|
|
|
|
|
|
|
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act
|
|
Filed herewith.
|
|
|
|
|
|
|
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
Filed herewith.
|
Exhibit No. |
Description
|
Method of Filing
|
||
101.1
|
|
The following consolidated financial statements from the Discovery Laboratories, Inc. Quarterly Report on Form 10-Q for the quarter ended September 30, 2013, formatted in Extensive Business Reporting Language ("XBRL"): (i) Balance Sheets as of September 30, 2013 (unaudited) and December 31, 2012, (ii) Statements of Operations (unaudited) for the three and nine months ended September 30, 2013 and September 30, 2012, (iii) Statements of Cash Flows (unaudited) for the nine months ended September 30, 2013 and September 30, 2012, and (v) Notes to consolidated financial statements.
|
|
|
|
|
|
|
|
101.INS
|
|
Instance Document
|
|
Previously filed.
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
Previously filed.
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
Previously filed.
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
Previously filed.
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
Previously filed.
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
Previously filed.
|
1 Year Discovery labs Chart |
1 Month Discovery labs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions